122 related articles for article (PubMed ID: 11199368)
1. Impact of screening examinations on survival in familial adenomatous polyposis.
Heiskanen I; Luostarinen T; Järvinen HJ
Scand J Gastroenterol; 2000 Dec; 35(12):1284-7. PubMed ID: 11199368
[TBL] [Abstract][Full Text] [Related]
2. Impact of Screening on Survival in Familial Adenomatous Polyposis.
Koskenvuo L; Pitkäniemi J; Rantanen M; Lepistö A
J Clin Gastroenterol; 2016 Jan; 50(1):40-4. PubMed ID: 26485107
[TBL] [Abstract][Full Text] [Related]
3. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee.
Bertario L; Presciuttini S; Sala P; Rossetti C; Pietroiusti M
Semin Surg Oncol; 1994; 10(3):225-34. PubMed ID: 8085100
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis.
Björk JA; Akerbrant HI; Iselius LE; Hultcrantz RW
Dis Colon Rectum; 2000 Dec; 43(12):1719-25. PubMed ID: 11156457
[TBL] [Abstract][Full Text] [Related]
5. Results of national registration of familial adenomatous polyposis.
Bülow S
Gut; 2003 May; 52(5):742-6. PubMed ID: 12692062
[TBL] [Abstract][Full Text] [Related]
6. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.
Bülow S; Bülow C; Nielsen TF; Karlsen L; Moesgaard F
Scand J Gastroenterol; 1995 Oct; 30(10):989-93. PubMed ID: 8545620
[TBL] [Abstract][Full Text] [Related]
7. Changing causes of mortality in patients with familial adenomatous polyposis.
Belchetz LA; Berk T; Bapat BV; Cohen Z; Gallinger S
Dis Colon Rectum; 1996 Apr; 39(4):384-7. PubMed ID: 8878496
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer.
Inoue Y; Ishida H; Ueno H; Kobayashi H; Yamaguchi T; Konishi T; Tomita N; Matsubara N; Ishida F; Hinoi T; Kanemitsu Y; Watanabe T; Sugihara K
Jpn J Clin Oncol; 2016 Sep; 46(9):819-24. PubMed ID: 27418167
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival.
Järvinen HJ
Gut; 1992 Mar; 33(3):357-60. PubMed ID: 1314763
[TBL] [Abstract][Full Text] [Related]
10. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis.
Nugent KP; Spigelman AD; Phillips RK
Dis Colon Rectum; 1993 Nov; 36(11):1059-62. PubMed ID: 8223060
[TBL] [Abstract][Full Text] [Related]
11. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options.
Church J; Burke C; McGannon E; Pastean O; Clark B
Dis Colon Rectum; 2003 Sep; 46(9):1175-81. PubMed ID: 12972960
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis in familial adenomatous polyposis. Results from the Polyposis Registry].
Bülow C; Bülow S; Nielsen TF; Karlsen L; Moesgaard FA
Ugeskr Laeger; 1996 Jul; 158(29):4188-90. PubMed ID: 8701535
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry.
Karstensen JG; Burisch J; Pommergaard HC; Aalling L; Højen H; Jespersen N; Schmidt PN; Bülow S
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2294-2300.e1. PubMed ID: 30743005
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of eight kindreds of familial adenomatous polyposis.
He YL; Zhang CH; Huang MJ; Cai SR; Zhan WH; Wang JP; Wang JF
World J Gastroenterol; 2004 Dec; 10(24):3659-61. PubMed ID: 15534926
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.
Björk J; Akerbrant H; Iselius L; Alm T; Hultcrantz R
Scand J Gastroenterol; 1999 Dec; 34(12):1230-5. PubMed ID: 10636071
[TBL] [Abstract][Full Text] [Related]
16. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
Mallinson EK; Newton KF; Bowen J; Lalloo F; Clancy T; Hill J; Evans DG
Gut; 2010 Oct; 59(10):1378-82. PubMed ID: 20660077
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis.
Nieuwenhuis MH; Mathus-Vliegen LM; Slors FJ; Griffioen G; Nagengast FM; Schouten WR; Kleibeuker JH; Vasen HF
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):374-8. PubMed ID: 17368237
[TBL] [Abstract][Full Text] [Related]
18. Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group.
De Cosse JJ; Bülow S; Neale K; Järvinen H; Alm T; Hultcrantz R; Moesgaard F; Costello C
Br J Surg; 1992 Dec; 79(12):1372-5. PubMed ID: 1336702
[TBL] [Abstract][Full Text] [Related]
19. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis.
Bülow C; Vasen H; Järvinen H; Björk J; Bisgaard ML; Bülow S
Gastroenterology; 2000 Dec; 119(6):1454-60. PubMed ID: 11113066
[TBL] [Abstract][Full Text] [Related]
20. Twenty years of familial adenomatosis polyposis syndromes in the Singapore Polyposis Registry: an analysis of outcomes.
Chew MH; Quah HM; Teh KL; Loi TT; Eu KW; Tang CL
Singapore Med J; 2011 Apr; 52(4):246-51. PubMed ID: 21552784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
